Search
for
Sort by
Research 211–240 of 1000+
- Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
- Self-Reported Hair Loss Following COVID-19: An Observational Study
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- A clinical case of a patient with mucocutaneous and musculoskeletal manifestations after COVID-19 vaccination
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
- Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- Cutaneous signs in COVID ‐19 patients: A review
- MAIT Cells in COVID-19: Heroes, Villains, or Both?
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients
- Clinical diagnosis of COVID-19: a prompt, feasible, and sensitive diagnostic tool for COVID-19 based on a 1,757-patient cohort (The AndroCoV Clinical Scoring for COVID-19 diagnosis)
- Clinical diagnosis of COVID-19: a prompt, feasible, and sensitive diagnostic tool for COVID-19 based on a 1,757-patient cohort (The AndroCoV Clinical Scoring for COVID-19 diagnosis).
- Pharmacological Activity of Cepharanthine
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Data-driven analysis to understand long COVID using electronic health records from the RECOVER initiative
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Coronavirus Infection and Cholesterol Metabolism
- Modulating the Antioxidant Response for Better Oxidative Stress-Inducing Therapies: How to Take Advantage of Two Sides of the Same Medal?
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship
- The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
- Management of long COVID-19 in children and adolescents: from diagnosis to therapeutically approaches
- COVID-19 pandemic and teledermatology in low-income regions
- Clinical Diagnosis of COVID-19: a Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1,757-Patient Cohort (The AndroCoV Clinical Scoring for COVID-19 Diagnosis).
- Evaluating the Metabolomic Profile and Anti-Pathogenic Properties of Cannabis Species